Finwizard61
Posted - 5 hours ago
$XERS Just remembering Mannix who was an ardent supporter of Xeris from its inception.
pascallambrecht
Posted - 11 hours ago
$XERS 5 dollar !!
pascallambrecht
Posted - 11 hours ago
$XERS i think it will go to 5 level
mountainmain
Posted - 15 hours ago
$XERS New higher high established after higher low of $2.73. It would be great if the higher low is at $3.25.
APIS_BULL
Posted - 15 hours ago
$XERS wanted to buy some $OKLO but might be dangerous now
Northwoodspeculator
Posted - 16 hours ago
$XERS come on now
What is really wrong with exchanging shares at these prices?
StarF
Posted - 16 hours ago
$XERS if only this could run and keep it's gains... Ffs
LurkerBoy
Posted - 16 hours ago
$XERS Another fake run? xD
PJACOB01
Posted - 17 hours ago
$XERS At what price will Ithaca get her squeeze?
Cats_and_Roses
Posted - 17 hours ago
$XERS also, the last time we saw this price range above $3.30 was mid-July 2021....it took a while to get back here
Cats_and_Roses
Posted - 17 hours ago
$XERS as Ithaca would say: Go Princess!
meistermell
Posted - 17 hours ago
$ESPR $XERS very
therealpoub
Posted - 17 hours ago
$XERS $SGMO my 2 favs are off to a good start this week. LFG!!
Finwizard61
Posted - 17 hours ago
$XERS Wow Xeris outperforming my NVIDIA again.. Just smashed thru $3.30.. Extremely Bullish.. headed for $4.00 and beyond..
ronday19200
Posted - 18 hours ago
$XERS
Alon_R
Posted - 20 hours ago
$XERS My personal opinion is as following:
Steady cf+ 2025(as expected by the CFO)-> may have move XERS SP next year to around 6-10$
Profitability if will occur 2026 -> may have move XERS SP to around 15-20$ Logically, it could take few or several months more than that to reach Profitability
And then we are likely to add XP-8121, that could leap XERS worth Anywhere!
Possible shortcut ->
Very significant Tech oriented deal, that Market powers will see as a massive game changer to Xeris. Like applying Xeriject tech on major drugs of a Big Pharma.
All in all, Xeris is an all around growth oriented Pharmaceutical company, with significant growth catalysts -> Tech collabs-as-franchises (and we may have see quite a bit of them in different sizes)
Drugs - While Recorlev flying, Gvoke growing as planned and Keveyis outstanding resiliency (this Trio optimization is likely around $500-600M mark)
Levothyroxine likely to join in 2027+/-
And maybe to triple everything (interesting).
NewEra8
Posted - 1 day ago
$XERS If i was like Aaron Rodgers, I’d say, “We lost to the Browns because my defense sucks and drops 5 interceptions in the game” but I am not Aaron Rodgers, I am Lamar Jackson, we played hard and came out on the losing end. Time to regroup and get ready for a tough Denver squad. Big Truzz
DarkOrb
Posted - 1 day ago
$XERS The thing is, if Levo (XP-8121) is a $350 million/year opportunity in the hands of Xeris, it is double or triple that owned by a larger pharma company. Oppenheimer just said in their October report that Levo could be a $1 billion/year opportunity. Whether because of the difficulty of access for a small company or their incompetence, these people struggle to sell. Look at how poorly they are doing compared to early projections on Gvoke (still less than 5% of TAM several years after launch). Look at how poorly they are doing compared to three year old projections on Recorlev (also 25% below the CPR threshold).
DarkOrb
Posted - 1 day ago
$XERS It's likely that a buyout, if any, will be driven by a desire to acquire either Levo (XP-8121) or the subcutaneous technology rather than the three existing drugs. If Levo is viewed by industry players as realistically being a $500 million to a billion annual revenue drug, this company is very likely going to be bought out before phase 3 is over.
BuyThisOne
Posted - 1 day ago
$XERS It took Halo 11 years to hit $20, 16 years to hit $40, 17 years to hit $50, 18 years to hit $60 and 20 years to get over $60 again. Xeris IPO was in 2018. So that would be: $20 in 2029 $40 in 2034 $60 in 2036 and then again in 2038. Similar companies with very similar structure of having internal products and tech they sell to others. Obviously we are not on exactly the same paths but this can give you a good idea of potential timelines here for stock price. That would put me at $4 million, $8 million and $12 million at each milestone in time. I think I can wait 11 more years for $12 million, lol. That would put Paul at $100 million plus and he is plenty rich already I don't think he will have a problem waiting to cash out. Prob same for others holding big chunks of this company. All long term investors with lots of wealth. Place your bets people! -
TramTrade
Posted - 1 day ago
$XERS I'm thinking big bios are watching our revenues for several quarters in order to gauge whether our products are profitable before BO
BuyThisOne
Posted - 1 day ago
$XERS The race is on between Lindy Biosciences, Elektrofi and Xeris(I'm sure there are others too) to see who gets a product through clinical trials first. Xeriject might be in the lead with Tepezza but we shall see in a few years. We are just at the beginning of this phase of medicine and drug delivery and things will never be the same. This is how scientific breakthroughs happen over decades, not years. Slow and steady win the race. Just look at all the huge players and how long they have been around advancing science and medicine. Nothing replaces experience when it comes to scientific breakthroughs. Even companies like SpaceX are all built upon the shoulders of giants. It is very exciting to get to watch this in real time. You are among a handful of people that even know this is happening yet billions of people will benefit from these efforts. Thanks Steve, Paul and Team for your efforts. I hope you all get very rich from this.
BuyThisOne
Posted - 1 day ago
$XERS I think any Xeriject product will take about 6 years to get to market from deal announcement. That means 5 more years for Tepezza and 6 years if Regeneron signs a deal. So 2030 for Tepezza and 2031 for Regeneron molecules. Before you try to say that is a long time, think about Covid. It has been 5 years since Covid was moving around the world. 5 years will pass in very short order and yes most of us will still be alive and have plenty of time to watch our investment grow and then more time from there to enjoy or continue to grow that investment with Xeris or another company. I hope to create enough wealth to help the next generations in my family buy homes and pay for education so they can also make their mark on the world instead of struggling to just get by like it seems so many are doing now. So many of us on here are very optimistic about the future and can be dreamers and that is ok. I think this is why we get so upset about people like AC and brod. Dregs of society. .
BuyThisOne
Posted - 2 days ago
$XERS Not sure why this is not showing on the main page. I don't block anyone so I can talk shit to you when I feel the need.
gimoozaabi
Posted - 2 days ago
@Aptos2024 sure, here you go $XERS https://xerisdd.com/gvoke-sales/
Aptos2024
Posted - 2 days ago
$XERS I'd love one of the folks who keep such records to compare Gvoke scrip numbers for 2023 Q2 v Q3 and 2024 Q2 v Q3?
SparkyReturns
Posted - 2 days ago
$XERS I’m gonna try to connect the dots or go down a rabbit hole (however you see it).
Amgen has been tight lipped since the collab was announced. Most of us think it’s been too long without news. They are in a race with Viridian to get a SubQ TED product to market. Highly lucrative (billions), highly competitive. Amgen has not disclosed the delivery system being used in the current SubQ Phase 3. Some have dismissed the possibility that they are using Xeris’ formulation in the Ph 3. But then I saw the other day doing a deep web dive that patients in the Ph 3 are being given a wearable device that auto-doses. Amgen also hasn’t publicly announced that detail either. They probably want an edge over Viridian with autodosing. And lo and behold, Xeris now has ties with BetaBionics for the dual pump autodosing. Beta is already an expert at single drug wearables. Could Xeris be supplying the formulation and Beta be supplying the wearable device to Amgen for their Ph 3? ⏱️ W T.
Cheers!
Northwoodspeculator
Posted - 2 days ago
$XERS what a positive week.
BuyThisOne
Posted - 2 days ago
$XERS Seeking alpha article is being corrected to be more clear. Glad to see there are professionals who are not just trying to spread false information. Everything else in the article was spot on.
Bullseye1285
Posted - 3 days ago
$XERS The Alpha article makes it seem like it’s the Xeris formulation that was approved in Asia. I didn’t see a press release from Xeris on it
“In September 2024, TEPEZZA received approval from Japan’s Ministry of Health, Labor, and Welfare, which is the first regulatory approval in Asia for the drug. This expands the global market for TEPEZZA. Xeris may receive milestone payments and royalties on future sales of the subcutaneous version when commercialized.”